Detalhe da pesquisa
1.
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.
Circulation
; 146(14): 1046-1055, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098051
2.
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.
Eur Heart J
; 42(43): 4455-4464, 2021 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423361
3.
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
Eur Heart J
; 42(6): 671-680, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459776
4.
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled.
Arterioscler Thromb Vasc Biol
; 43(7): 1334-1337, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199158
5.
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
J Pathol
; 246(3): 331-343, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043421
6.
Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice.
J Pathol
; 233(2): 148-58, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24519156
7.
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
J Cachexia Sarcopenia Muscle
; 15(1): 412-424, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158636
8.
Mechanisms of FGFR-mediated carcinogenesis.
Biochim Biophys Acta
; 1823(4): 850-60, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22273505
9.
Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled Analysis.
JACC Heart Fail
; 11(6): 702-712, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872213
10.
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation.
Eur J Heart Fail
; 25(7): 970-977, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062866
11.
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
J Am Coll Cardiol
; 81(19): 1902-1914, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164523
12.
Health status across major subgroups of patients with heart failure and preserved ejection fraction.
Eur J Heart Fail
; 25(9): 1623-1631, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974746
13.
The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.
J Exp Med
; 203(7): 1651-6, 2006 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16801397
14.
Fgfr3 regulates development of the caudal telencephalon.
Dev Dyn
; 240(6): 1586-99, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21491541
15.
Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced.
Eur J Heart Fail
; 24(4): 708-715, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957660
16.
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced.
Eur J Heart Fail
; 24(12): 2297-2304, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194680
17.
Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Eur J Heart Fail
; 24(10): 1869-1878, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796209
18.
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
JACC Heart Fail
; 10(7): 512-524, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670067
19.
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.
J Am Coll Cardiol
; 80(1): 1-18, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772911
20.
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.
Nat Med
; 28(12): 2512-2520, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471037